[Federal Register Volume 67, Number 202 (Friday, October 18, 2002)]
[Notices]
[Pages 64382-64383]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-26536]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 02076]
Expansion of HIV/AIDS/STD Surveillance, Care, and Prevention
Activities in the Republic of Tanzania; Notice of Award of Funds
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2002 funds for a cooperative agreement
program for the expansion of HIV/AIDS/STD surveillance, care, and
prevention activities in the Republic of Tanzania.
The purpose of this cooperative agreement is to improve HIV/AIDS
surveillance, care, and prevention capacity and activities in Tanzania.
This will be accomplished by cooperation between CDC and the Ministry
of Health National AIDS Control Program (MOH/NACP) of Tanzania. These
collaborative activities could profoundly change the focus and
activities of the Tanzania National AIDS Policy. Most importantly,
having a better understanding of the association between specific
behaviors, STDs, and HIV prevalence will likely
[[Page 64383]]
improve AIDS control programs and prevention efforts in Tanzania and
eventually throughout sub-Saharan Africa. The U.S. Government seeks to
reduce the impact of HIV/AIDS in specific countries within sub-Saharan
Africa, Asia, and the Americas through its Global AIDS Program (GAP).
CDC has initiated its Global AIDS Program to strengthen capacity and
expand activities in the areas of (1) HIV primary prevention; (2) HIV
care, support, and treatment; and (3) capacity and infrastructure
development, especially for surveillance. Targeted countries represent
those with the most severe epidemics and the highest number of new
infections. They also represent countries where the potential for
impact is greatest and where U.S. government agencies are already
active. Tanzania is one of these targeted countries.
CDC is working in a collaborative manner with national governments
and other agencies to develop programs of assistance to address the
HIV/AIDS epidemic in GAP countries. In particular, CDC's mission in
Tanzania is to work with Tanzanian and international partners in
discovering and applying effective interventions to prevent HIV
infection and associated illness and death from AIDS.
Tanzania has approximately 31 million people. In 1997, NACP
estimated that 2.4 million (8 percent) would be HIV-infected by the
year 2000. In 1998, the MOH reported that the HIV seroprevalence of
pregnant women in four sentinel districts ranged from 12 to 24 percent.
Also for 1998, the MOH reported that HIV seroprevalence among male
blood donors was 9 percent, while the rate was 12 percent among female
donors. The Adult Morbidity and Mortality Project recently reported
that HIV/AIDS and TB were the leading causes of death in 15 to 59 year-
old men and women in three study areas. These statistics suggest the
need for the expansion and improvement of a range of surveillance,
care, and prevention activities and services.
Accurate surveillance is the mainstay of public health programs,
providing essential information for focusing prevention activities,
allocating resources, and monitoring effectiveness of programs.
Additionally, gaps in care and prevention activities are factors that
must be addressed to reduce the epidemic's burdensome impact in
Tanzania. The prevention and control of HIV/AIDS in Tanzania will
continue to depend on the availability of accurate surveillance data
and the continuation and expansion of basic care and prevention
activities.
B. Eligible Applicants
Assistance will be provided only to the National AIDS Control
Program (NACP) of the Tanzania Ministry of Health (MOH). No other
applications are solicited.
The NACP is currently the only appropriate and qualified
organization to conduct a specific set of activities supportive of the
CDC Global AIDS Program's (GAP) technical assistance to Tanzania for
the following reasons:
1. The NACP is uniquely positioned, in terms of legal authority,
ability, and credibility among Tanzanian citizens, to collect crucial
data on HIV/AIDS prevalence and incidence, as well as other health
information.
2. The NACP has established mechanisms to access health
information, enabling it to immediately become engaged in the
activities listed in this announcement.
3. The purpose of the announcement is to build upon the existing
framework of health information and activities that the MOH itself has
collected or initiated.
4. The Ministry of Health in Tanzania has been mandated by the
Tanzanian constitution to coordinate and implement activities necessary
for the control of epidemics, including HIV/AIDS and STDs.
C. Availability of Funds
Approximately $1,000,000 is available in FY 2002 to fund this
award. It is expected that the award will begin on or about June 1,
2002, and will be made for a 12-month budget period within a project
period of 5 years. Approximately $500,000 will be available for years
2-5 of the project. Annual funding estimates may change.
Continuation awards within the approved project period will be made
on the basis of satisfactory progress as evidenced by required reports
and the availability of funds.
All requests for funds, including the budget contained in the
application, shall be stated in U.S. dollars. Once an award is made,
the Department of Health and Human Services (DHHS) will not compensate
foreign grantees for currency exchange fluctuations through the
issuance of supplemental awards.
Use of Funds
Funds received under this announcement may not be used for the
direct purchase of anti-retroviral drugs to treat established HIV
infection, occupational exposures, and non-occupational exposures and
will not be used for the purchase of instruments and reagents to
conduct the necessary laboratory monitoring for patient care.
Applicants may contract with other organizations under these
cooperative agreements, however, applicants must perform a substantial
portion of the activities including program management and operations,
and delivery of prevention services for which funds are requested.
The costs that are generally allowable in grants to domestic
organizations are likewise allowable to foreign institutions and
international organizations, with the following exceptions:
Indirect Costs: With the exception of the American University,
Beirut, the Gorgas Memorial Institute, and the World Health
Organization, indirect costs will not be paid (either directly or
through a sub-award) to organizations, located outside the
territorial limits of the United States or to international
organizations regardless of their location.
No funds appropriated under this Act shall be used to carry out any
program of distributing sterile needles or syringes for the hypodermic
injection of any illegal drug.
D. Where To Obtain Additional Information
This and other CDC announcements can be found on the CDC home page
Internet address--http://www.cdc.gov. Click on ``Funding'' then
``Grants and Cooperative Agreements.''
To obtain business management technical assistance, contact:
Cynthia Collins, Grants Management Specialist, Grants Management
Branch, Procurement and Grants Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road, Room 3000, Atlanta, GA 30341-4146.
Telephone number: 770-488-2757. e-mail: [email protected].
For program technical assistance, contact: Eddas M. Bennett, Deputy
Director, CDC Tanzania AIDS Program, National Center for HIV, STD, and
TB Prevention, Centers for Disease Control and Prevention (CDC), 140
Msese Road, Dar es Salaam, Tanzania. Telephone: 2 666 010 x4164. e-
mail: [email protected].
Dated: October 9, 2002.
Edward J. Schultz,
Deputy Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 02-26536 Filed 10-17-02; 8:45 am]
BILLING CODE 4163-18-P